Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

Wed, 14th Aug 2019 06:45

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stadawill be careful about buying businesses and companiesoutright, and for now will focus mainly on striking productionand development deals with partners, the company's chiefexecutive told Reuters.

"We are very selective but we take a look at everything,"said CEO Peter Goldschmidt, who took the helm a year ago.

The company, majority owned by buyout firms Bain and Cinvensince 2017, sells consumer healthcare products such aspainkillers, sunscreen lotions as well as biosimilar and genericdrugs, which are cheaper copies of established pharmaceuticalsthat have lost patent protection.

The new owners at the time were widely expected to pursueother deals to combine Stada with a peer in consumer healthcareor generic drug markets, but the German company has so farstayed away from larger deals.

"We have very good organic growth. Our first goal is to havegood partnerships," he added, referring to collaboration dealswith developers and producers.

Stada is expected to be among the suitors for a portfolio ofdrugs for sale in western Europe that Japan's TakedaPharmaceutical is divesting to trim its debt followingthe $59 billion purchase of Shire, sources close to the mattertold Reuters last month.

Goldschmidt declined to comment on the transaction, sayingthere was no shortage of alternative deals to pursue for Stada.

"There are five or six comparable opportunities, that arecurrently in the market or will come to the market," the CEOsaid.

The generic drugmaker on Wednesday reported an increase inadjusted earnings before interest, taxes, depreciation andamortization (EBITDA) of 13% to 295 million euros ($310.61million) during the fist half.

Sales during the first six months of the year gained 11% to1.26 billion euros, helped by growth in generic prescriptiondrugs and consumer health products.

Stada agreed in June to buy six consumer brands, includingitch relief cream Eurax and Tixylix cough liquids, from Britishdrugmaker GlaxoSmithKline for an undisclosed price tobolster its presence in Europe.

The Hesse-based company is focusing on Europe and has shiedaway from doing business in the United States, where genericdrug companies have come under price pressure.

($1 = 0.8950 euros)(Reporting by Ludwig Burger and Patricia Weiss,Editing by Tassilo Hummel and Sherry Jacob-Phillips)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.